Study details
Enrolling now
Effectiveness and Safety of Zavegepant in Adults Using CGRP Preventive Medications for Migraine Treatment
Mayo Clinic
NCT IDNCT06401642ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
200
Study length
about 3 years
Ages
18+
Locations
1 site in AZ
What this study is about
Researchers are testing whether zavegepant, a medication, can effectively treat migraine attacks in adults who are already taking medications to prevent migraines. The trial will also evaluate how well zavegepant is tolerated by participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Zavegepant
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
zavegepant
Endpoints
Secondary: Adverse events, Discontinuation due to adverse events, Serious adverse events
Body systems
Neurology